Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trial
Objectives and intervention Bloodstream infection, the presence of viable micro-organisms in the blood, is a prevalent clinical event associated with substantial mortality. Patient outcomes may be improved when the causative micro-organism is identified quickly. We assessed the cost-effectiveness of...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMJ Publishing Group
2021-10-01
|
| Serija: | BMJ Open |
| Online dostop: | https://bmjopen.bmj.com/content/11/10/e044623.full |